News & Updates

Older adults with well-controlled metabolic comorbidities exhibit immune response to influenza vaccine, as shown in the results of the DYNAMIC study. Notably, physical activity further increases immune response particularly for influenza A/H3N2.

Patients, family members, and healthcare professionals experience multifaceted losses and grief during this COVID-19 pandemic, according to a Singapore study. Moreover, the impact of COVID-19 and current societal restrictions causes those afflicted to fear for their future, further worsening their emotional and psychological well-being.

In thrombotic stroke patients at high risk of ischaemic stroke recurrence, prasugrel was as effective as clopidogrel in reducing the composite incidence of ischaemic stroke, MI, and death from other vascular causes, the phase III PRASTRO-III study has shown.

An extended 4.5-year follow-up of the phase III KEYNOTE-240 trial showed that pembrolizumab continued to provide clinically meaningful improvements in the dual primary endpoints of overall survival (OS) and progression-free survival (PFS), with a manageable safety profile, vs placebo in patients with sorafenib-treated advanced hepatocellular carcinoma (HCC).

Among prostate cancer patients on androgen deprivation therapy (ADT), a small prostate and higher reductions in testosterone levels appear to aggravate storage symptoms, a recent study has found.